APA (7th ed.) Citation

Y, K., N, S., S, E., R, K., J, M., A, T., . . . T, S. (2025). Short-term outcomes of a phase II trial of perioperative capecitabine plus oxaliplatin therapy for advanced gastric cancer with extensive lymph node metastases (OGSG1701). Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 28(1), 112. https://doi.org/10.1007/s10120-024-01564-9

Chicago Style (17th ed.) Citation

Y, Kimura, et al. "Short-term Outcomes of a Phase II Trial of Perioperative Capecitabine Plus Oxaliplatin Therapy for Advanced Gastric Cancer with Extensive Lymph Node Metastases (OGSG1701)." Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 28, no. 1 (2025): 112. https://doi.org/10.1007/s10120-024-01564-9.

MLA (9th ed.) Citation

Y, Kimura, et al. "Short-term Outcomes of a Phase II Trial of Perioperative Capecitabine Plus Oxaliplatin Therapy for Advanced Gastric Cancer with Extensive Lymph Node Metastases (OGSG1701)." Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, vol. 28, no. 1, 2025, p. 112, https://doi.org/10.1007/s10120-024-01564-9.